Participation is open to worldwide institutions.
    Read More
    Since 1998, an Annual Meeting of the IELSG investigators has been regularly held.
    Read More
    The IELSG Newsletter informs about studies, meetings and other research activities.
    Read More
    The results are presented to major congresses and published into peer-reviewed journals.
    Read More

Fighting cancer through research. You can support us by making a donation, however large or small.

Support Us


  • IELSG38 – Chlorambucil plus subcutaneous rituximab induction and maintenance in MALT lymphoma
    Reference IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. Link
    Author(s) Stathis A, Pirosa MC, Orsucci L, Feugier P, Tani M, Ghesquières H, Musuraca G, Rossi FG, Merli F, Guièze R, Gyan E, Gini G, Marino D, Gressin R, Morschhauser F, Cavallo F, Palombi F, Conconi A, Tessoulin B, Tilly H, Zanni M, Cabras MG, Capochiani E, Califano C, Celli M, Pulsoni A, Angrilli F, Occhini U, Casasnovas RO, Cartron G, Devizzi L, Haioun C, Liberati AM, Houot R, Merli M, Pietrantuono G, Re F, Spina M, Landi F, Cavalli F, Bertoni F, Rossi D, Ielmini N, Borgo E, Luminari S, Zucca E, Thieblemont C.
    Study IELSG38
  • IELSG Annual Meeting 2024

    The next Annual Meeting of the International Extranodal Lymphoma Study Group (IELSG) will be held on March 8-9, 2024 in Stresa (Italy) at Hotel La Palma.

    REGISTRATION is open.

    Details of the program will follow closer to the event.


  • IELSG50
    IELSG50 Pembrolizumab and radiotherapy for previously untreated patients with limited-stage NK/T cell lymphoma who are not eligible for chemotherapy Participants required: 30… Read more: IELSG50
  • IELSG45
    IELSG45 Randomized phase II trial on fitness- and comorbidity-tailored treatment in elderly patients with newly diagnosed primary CNS lymphoma (FIORELLA Trial) Participants… Read more: IELSG45
  • IELSG44
    IELSG44 FDG-PET evaluation for marginal zone lymphoma and its prognostic role: an international multicenter retrospective analysis (PIMENTO) Participants required: 350 Investigator responsible(s):… Read more: IELSG44